Showing results (121-130 of 345) with videos related to
Sort By:
Pageof 35
International Journal of Immunopharmacology|January 1, 1990
The potential of cyclosporin A as an anti-tumour agentG McLachlan, L M Smart, H M Wallace, et al.Transplantation|September 27, 1995
Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipientsS Satoh, A W Thomson, K Nakamura, et al.Clinical and Experimental Immunology|April 1, 1991
Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin AC Horrocks, J I Duncan, A M Oliver, et al.Biochemical Pharmacology|April 1, 1984
Enhancement of high dose cyclosporin A toxicity by frusemideP H Whiting, C Cunningham, A W Thomson, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liverM L Drakes, L Lu, V M Subbotin, et al.Gut|July 17, 2003
Liver tolerance mediated by antigen presenting cells: fact or fiction?A H Lau, A de Creus, L Lu, et al.Immunology|March 1, 1986
Influence of tumour carriage on the production of lymphokines affecting macrophage behaviourL C McIntosh, L M Morrice, Y Udagawa, et al.The Cochrane Database of Systematic Reviews|November 1, 2001
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fracturesI D Cameron, H H Handoll, T P Finnegan, et al.The Cochrane Database of Systematic Reviews|October 18, 2000
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fracturesI D Cameron, H H Handoll, T P Finnegan, et al.Physiotherapy|February 8, 2011
ICF participation restriction is common in frail, community-dwelling older people: an observational cross-sectional studyN Fairhall, C Sherrington, S E Kurrle, et al.Pageof 35